2020 was an exceptional and challenging year. Like many others we at Aiforia had to adapt to the new circumstances posed by the ongoing COVID-19 pandemic. Despite the global turbulence we continue to serve scientists and medical professionals across preclinical, academic, and clinical labs around the globe.
The novel coronavirus pandemic forced much of the world’s population to work remotely and adjust their routines. The need for cloud-based solutions has therefore never been higher. This changing landscape and demand is certainly reflected in our growth. In 2020 the number of Aiforia users increased by a record setting 87% to a total of over 3,000 users in over 50 countries.
I would like to thank our customers, partners and of course the team at Aiforia for their diligence and resilience during these difficult times. Our team of scientists, software developers, and business professionals are key in driving our accomplishments from the past year; to name a few:
Secured a U.S. patent for high-speed AI training tool in pathology related image analysis
The multitude of exciting projects and partnerships with our customers from Charles River Laboratories, the Mayo Clinic, the University of Oxford, and many more
During the year we also made huge strides in developing our clinical offering. Aiforia presented a preview of its clinical solutions for AI-assisted diagnostics of prostate cancer and in 2021 we will unveil our platform combining powerful AI-based image analytics and integrated image viewers with reporting tools to support pathologists' decision making in the clinical workflow. Our science team is also developing a suite of core AI models for the diagnosis of some of the world’s most common cancers such as prostate and breast, as well as for other major diseases: malaria, fatty liver diseases, and more.
Looking ahead I am excited for Aiforia, our partners and our customers to keep building on these successes. Our mission is to outfit healthcare professionals with the digital solutions they need for the shifting landscape of medicine. This rings particularly true as we turn the corner on a new year, a new normal, and a continued need to adapt our way of working.
I would like to wish you all a happy and healthy holiday period!